Search

Topical phenytoin effect on pressure ulcers healing: A literature review of the evidence

A pressure ulcer (PU) is a localised injury to the skin and / or underlying tissue usually over a bony prominence, because of pressure, or pressure in combination with shear (EPUAP/ NPUAP 2009/PPPPIA 2014). Bennett et al. [1] claimed total...

Melasma treatment – what have we achieved in 42 years?

Melasma is a hyperpigmentation disorder which has been the subject of intense research over the last 40 years. As yet no definitive therapeutic strategy has been demonstrated to eradicate it or to avoid relapse. The author provides an up to...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...

In conversation with Professor David Sines

In January 2016 a new voluntary regulatory register was established – the Joint Council for Cosmetic Practitioners (JCCP), chaired by Professor David Sines. Since that time the JCCP has met with challenges from many within the aesthetics industry. We spoke...